The FDA has issued a warning about counterfeit Ozempic medications, sharing the lot numbers and serial numbers of products ...

With the investment, the production capacity will have "a considerable ... the active ingredient in Ozempic and Wegovy. Novo ...

The US Food and Drug Administration (FDA) on Monday urged patients and healthcare providers to verify the authenticity of ...

Current developments in the health sector include Novo Nordisk's warning about counterfeit Ozempic in the US, Sandoz's antitrust lawsuit against Amgen, and rising concerns in the biotech industry due ...

While much of the recent GLP-1 saga has been written in the U.S., Novo Nordisk continues to expand its semaglutide empire across the globe and make inroads into large markets like Brazil. | Looking to ...

SYNT-101 offers a novel approach to weight loss by temporarily altering nutrient absorption in the small intestine. Unlike ...

Novo Nordisk will invest $1.09 billion in Brazil to enhance production of injectable drugs for obesity and diabetes. This ...

Weight loss injections have boomed over the last few years, so much so that it has spawned a rise in production ... the pharmaceutical company that markets Ozempic, notified the FDA on April ...

(MENAFN- The Rio Times) Novo Nordisk, the Danish pharmaceutical leader ... into enzyme production for semaglutide-based drugs like Ozempic and Wegovy. The company's decision underscores Brazil's ...

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic and Mounjaro, the pharmaceutical company says.

With the investment, the production capacity ... the active ingredient in Ozempic and Wegovy. Novo Nordisk's investment comes as Brazilian pharmaceutical companies are preparing to make a push ...